Vestmark Advisory Solutions’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$225K Sell
2,881
-2,727
-49% -$213K ﹤0.01% 740
2025
Q1
$406K Buy
5,608
+2,860
+104% +$207K 0.01% 553
2024
Q4
$203K Sell
2,748
-656
-19% -$48.6K 0.01% 559
2024
Q3
$225K Sell
3,404
-2,854
-46% -$188K 0.01% 511
2024
Q2
$578K Sell
6,258
-828
-12% -$76.5K 0.02% 380
2024
Q1
$677K Buy
7,086
+252
+4% +$24.1K 0.03% 353
2023
Q4
$521K Buy
6,834
+793
+13% +$60.5K 0.03% 341
2023
Q3
$419K Sell
6,041
-6,932
-53% -$480K 0.03% 309
2023
Q2
$1.22M Buy
12,973
+1,781
+16% +$168K 0.05% 408
2023
Q1
$926K Sell
11,192
-560
-5% -$46.3K 0.04% 455
2022
Q4
$877K Sell
11,752
-20
-0.2% -$1.49K 0.04% 453
2022
Q3
$973K Sell
11,772
-5,324
-31% -$440K 0.05% 391
2022
Q2
$1.63M Buy
17,096
+3,049
+22% +$290K 0.09% 279
2022
Q1
$1.65M Buy
14,047
+571
+4% +$67.2K 0.09% 274
2021
Q4
$1.75M Buy
13,476
+731
+6% +$94.7K 0.1% 255
2021
Q3
$1.44M Buy
12,745
+20
+0.2% +$2.26K 0.1% 267
2021
Q2
$1.32M Buy
12,725
+423
+3% +$43.8K 0.09% 272
2021
Q1
$1.03M Buy
12,302
+6,031
+96% +$504K 0.09% 281
2020
Q4
$572K Buy
6,271
+2
+0% +$182 0.06% 326
2020
Q3
$500K Sell
6,269
-448
-7% -$35.7K 0.07% 323
2020
Q2
$464K Buy
6,717
+636
+10% +$43.9K 0.07% 318
2020
Q1
$382K Buy
+6,081
New +$382K 0.07% 311
2019
Q4
Sell
-6,126
Closed -$449K 338
2019
Q3
$449K Sell
6,126
-795
-11% -$58.3K 0.07% 319
2019
Q2
$426K Sell
6,921
-867
-11% -$53.4K 0.07% 316
2019
Q1
$497K Buy
+7,788
New +$497K 0.09% 283